|
1
|
Cha C, DeMatteo RP and Blumgart LH:
Surgery and ablative therapy for hepatocellular carcinoma. J Clin
Gastroenterol. 35(Suppl 2): S130–S137. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Forner A, Llovet JM and Bruix J:
Hepatocellular carcinoma. Lancet. 379:1245–1255. 2012. View Article : Google Scholar
|
|
3
|
Carr BI: Hepatocellular carcinoma: current
management and future trends. Gastroenterology. 127(Suppl 1):
S218–S224. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cai X, Hagedorn CH and Cullen BR: Human
microRNAs are processed from capped, polyadenylated transcripts
that can also function as mRNAs. RNA. 10:1957–1966. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee Y, Kim M, Han J, et al: MicroRNA genes
are transcribed by RNA polymerase II. EMBO J. 23:4051–4060. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gregory RI, Yan KP, Amuthan G, et al: The
microprocessor complex mediates the genesis of microRNAs. Nature.
432:235–240. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chendrimada TP, Gregory RI, Kumaraswamy E,
et al: TRBP recruits the Dicer complex to Ago2 for microRNA
processing and gene silencing. Nature. 436:740–744. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Han J, Lee Y, Yeom KH, et al: Molecular
basis for the recognition of primary microRNAs by the Drosha-DGCR8
complex. Cell. 125:887–901. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Valencia-Sanchez MA, Liu J, Hannon GJ and
Parker R: Control of translation and mRNA degradation by miRNAs and
siRNAs. Genes Dev. 20:515–524. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Plasterk RH: Micro RNAs in animal
development. Cell. 124:877–881. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nusse R and Varmus HE: Many tumors induced
by the mouse mammary tumor virus contain a provirus integrated in
the same region of the host genome. Cell. 31:99–109. 1982.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Peifer M and Polakis P: Wnt signaling in
oncogenesis and embryogenesis - a look outside the nucleus.
Science. 287:1606–1609. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Giles RH, van Es JH and Clevers H: Caught
up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta.
1653:1–24. 2003.PubMed/NCBI
|
|
14
|
Nelson WJ and Nusse R: Convergence of Wnt,
β-catenin, and cadherin pathways. Science. 303:1483–1487. 2004.
|
|
15
|
Brantjes H, Barker N, van Es J and Clevers
H: TCF: Lady Justice casting the final verdict on the outcome of
Wnt signalling. Biol Chem. 383:255–261. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hecht A, Vleminckx K, Stemmler MP, van Roy
F and Kemler R: The p300/CBP acetyltransferases function as
transcriptional coactivators of β-catenin in vertebrates. EMBO J.
19:1839–1850. 2000.
|
|
17
|
Takemaru KI and Moon RT: The
transcriptional coactivator CBP interacts with β-catenin to
activate gene expression. J Cell Biol. 149:249–254. 2000.
|
|
18
|
Kramps T, Peter O, Brunner E, et al:
Wnt/wingless signaling requires BCL9/legless-mediated recruitment
of Pygopus to the nuclear β-catenin-TCF complex. Cell.
109:47–60. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Graham TA, Ferkey DM, Mao F, Kimelman D
and Xu W: Tcf4 can specifically recognize β-catenin using
alternative conformations. Nat Struct Biol. 8:1048–1052. 2001.
|
|
20
|
Hoverter NP and Waterman ML: A Wnt-fall
for gene regulation: repression. Sci Signal. 1:pe432008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
El-Tanani MK, Barraclough R, Wilkinson MC
and Rudland PS: Regulatory region of metastasis-inducing DNA is the
binding site for T cell factor-4. Oncogene. 20:1793–1797. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
El-Tanani M, Barraclough R, Wilkinson MC
and Rudland PS: Metastasis-inducing DNA regulates the expression of
the osteopontin gene by binding the transcription factor Tcf-4.
Cancer Res. 61:5619–5629. 2001.PubMed/NCBI
|
|
23
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP
and Wei WI: Mature miR-184 as potential oncogenic microRNA of
squamous cell carcinoma of tongue. Clin Cancer Res. 14:2588–2592.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mascaux C, Laes JF, Anthoine G, et al:
Evolution of microRNA expression during human bronchial squamous
carcinogenesis. Eur Respir J. 33:352–359. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Arndt GM, Dossey L, Cullen LM, et al:
Characterization of global microRNA expression reveals oncogenic
potential of miR-145 in metastatic colorectal cancer. BMC Cancer.
9:3742009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kozaki K, Imoto I, Mogi S, Omura K and
Inazawa J: Exploration of tumor-suppressive microRNAs silenced by
DNA hypermethylation in oral cancer. Cancer Res. 68:2094–2105.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lee EJ, Gusev Y, Jiang J, et al:
Expression profiling identifies microRNA signature in pancreatic
cancer. Int J Cancer. 120:1046–1054. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Takahashi-Yanaga F and Kahn M: Targeting
Wnt signaling: can we safely eradicate cancer stem cells? Clin
Cancer Res. 16:3153–3162. 2010. View Article : Google Scholar : PubMed/NCBI
|
